Annual Cash & Cash Equivalents
$21.94 M
-$15.26 M-41.03%
December 31, 2023
Summary
- As of February 7, 2025, LTRN annual cash & cash equivalents is $21.94 million, with the most recent change of -$15.26 million (-41.03%) on December 31, 2023.
- During the last 3 years, LTRN annual cash & cash equivalents has risen by +$2.71 million (+14.09%).
- LTRN annual cash & cash equivalents is now -57.42% below its all-time high of $51.52 million, reached on December 31, 2021.
Performance
LTRN Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$8.10 M
-$4.87 M-37.56%
September 30, 2024
Summary
- As of February 7, 2025, LTRN quarterly cash and cash equivalents is $8.10 million, with the most recent change of -$4.87 million (-37.56%) on September 30, 2024.
- Over the past year, LTRN quarterly cash and cash equivalents has dropped by -$17.47 million (-68.31%).
- LTRN quarterly cash and cash equivalents is now -90.04% below its all-time high of $81.37 million, reached on March 31, 2021.
Performance
LTRN Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
LTRN Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -41.0% | -68.3% |
| 3 y3 years | +14.1% | -85.2% |
| 5 y5 years | +4827.6% | - |
LTRN Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -57.4% | at low | -84.3% | at low |
| 5 y | 5-year | -57.4% | +1680.7% | -90.0% | +1177.6% |
| alltime | all time | -57.4% | +4827.6% | -90.0% | +1177.6% |
Lantern Pharma Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $8.10 M(-37.6%) |
| Jun 2024 | - | $12.98 M(-29.3%) |
| Mar 2024 | - | $18.36 M(-16.3%) |
| Dec 2023 | $21.94 M(-41.0%) | $21.94 M(-14.2%) |
| Sep 2023 | - | $25.57 M(-10.0%) |
| Jun 2023 | - | $28.42 M(-12.5%) |
| Mar 2023 | - | $32.48 M(-12.7%) |
| Dec 2022 | $37.20 M | $37.20 M(-5.2%) |
| Sep 2022 | - | $39.26 M(-9.5%) |
| Jun 2022 | - | $43.36 M(-7.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $46.65 M(-9.5%) |
| Dec 2021 | $51.52 M(+167.9%) | $51.52 M(-5.8%) |
| Sep 2021 | - | $54.67 M(-10.9%) |
| Jun 2021 | - | $61.35 M(-24.6%) |
| Mar 2021 | - | $81.37 M(+323.2%) |
| Dec 2020 | $19.23 M(+1460.8%) | $19.23 M(-7.6%) |
| Sep 2020 | - | $20.80 M(-12.6%) |
| Jun 2020 | - | $23.80 M(+3652.5%) |
| Mar 2020 | - | $634.20 K(-48.5%) |
| Dec 2019 | $1.23 M(+176.7%) | $1.23 M |
| Dec 2018 | $445.20 K | - |
FAQ
- What is Lantern Pharma annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Lantern Pharma?
- What is Lantern Pharma annual cash & cash equivalents year-on-year change?
- What is Lantern Pharma quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Lantern Pharma?
- What is Lantern Pharma quarterly cash and cash equivalents year-on-year change?
What is Lantern Pharma annual cash & cash equivalents?
The current annual cash & cash equivalents of LTRN is $21.94 M
What is the all time high annual cash & cash equivalents for Lantern Pharma?
Lantern Pharma all-time high annual cash & cash equivalents is $51.52 M
What is Lantern Pharma annual cash & cash equivalents year-on-year change?
Over the past year, LTRN annual cash & cash equivalents has changed by -$15.26 M (-41.03%)
What is Lantern Pharma quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of LTRN is $8.10 M
What is the all time high quarterly cash and cash equivalents for Lantern Pharma?
Lantern Pharma all-time high quarterly cash and cash equivalents is $81.37 M
What is Lantern Pharma quarterly cash and cash equivalents year-on-year change?
Over the past year, LTRN quarterly cash and cash equivalents has changed by -$17.47 M (-68.31%)